Publications in collaboration with researchers from National Institute of Cardiovascular Diseases (1)

2022

  1. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation

    New England Journal of Medicine, Vol. 387, Núm. 11, pp. 978-988